Patrick van Berkel
Chief Tech/Sci/R&D Officer at ADC THERAPEUTICS SA
Net worth: 3 M $ as of 2024-03-30
Profile
Patrick van Berkel is currently the Chief Scientific Officer at ADC Therapeutics SA. Prior to his current position, he worked at Genmab A as the VP-Antibody, Technology & Chemistry from 2003 to 2012.
Dr. van Berkel holds a doctorate degree from the University of Leiden, which he obtained in 1998.
He also has an undergraduate degree from Radboud University Nijmegen, which he received in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0.76% | 2023-01-31 | 623,467 ( 0.76% ) | 3 M $ | 2024-03-30 |
Patrick van Berkel active positions
| Companies | Position | Start |
|---|---|---|
| ADC THERAPEUTICS SA | Chief Tech/Sci/R&D Officer | 2012-07-31 |
Former positions of Patrick van Berkel
| Companies | Position | End |
|---|---|---|
| GENMAB A/S | Chief Tech/Sci/R&D Officer | 2011-12-31 |
Training of Patrick van Berkel
| University of Leiden | Doctorate Degree |
| Radboud University Nijmegen | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GENMAB A/S | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
- Stock Market
- Insiders
- Patrick van Berkel
